L-proline catalyzed synthesis of structurally diverse 1,4-dihydropyridines fused with medicinally privileged heterocyclic systems

Current Organocatalysis

Volumn 1, Issue 1, 2014, Pages 51-58

  Khandelwal, Sarita ^a   Rajawat, Anshu ^a   Kumar, Mahendra ^a  

^a UNIVERSITY OF RAJASTHAN   (India)

Author keywords

1, 4 dihydropyridines; 2 aminobenzothiazole; Chromenoindenopyridines; Chromenoquinolines; Indenoquinolines; Knoevenagel condensation; L proline; Medicinally privileged heterocycles; Michael addition; Multicomponent reaction; Organocatalysis; Pyranoquinolines

Indexed keywords

EID: 84928667701     PISSN: 22133372     EISSN: 22133380     Source Type: Journal    
DOI: 10.2174/22133372114016660004     Document Type: Article

References (56)

1. Tietze, L.F.; Brasche, G.; Gericke, K.M. Domino Reactions in Organic Synthesis; Wiley-VCH: Weinheim, Germany, 2006
2. Powner, M.W.; Sutherland, J.D.; Szostak, J.W. Synthesis of activated pyrimidine ribonucleotides in prebiotically plausible conditions. J. Am. Chem. Soc., 2010, 132, 16677-16688
3. Chen, X.H.; Xu, X.Y.; Liu, H.; Cun, L.F.; Gong, L.Z. Highly enantioselective organocatalytic Biginelli reaction. J. Am. Chem. Soc., 2006, 128, 14802-14803
4. Jiang, B.; Tu, S.J.; Kaur, P.; Wever, W.; Li, G. Four-component domino reaction leading to multifunctionalized quinazolines. J. Am. Chem. Soc., 2009, 131, 11660-11661.
5. Marson, C.M. Multicomponent and sequential organocatalytic reactions: diversity with atom-economy and enantiocontrol. Chem. Soc. Rev., 2012, 41(23), 7712-7722
6. Graaff, C.D.; Ruijter, E.; Orru, R.V.A. Recent developments in asymmetric multicomponent reactions. Chem. Soc. Rev., 2012, 41, 3969-4009
7. Domling, A.; Wang, W.; Wang, K. Chemistry and biology of multicomponent reactions. Chem. Rev., 2012, 112, 3083-3135.
8. Wan, J.-P.; Liu, Y. Recent advances in new multicomponent synthesis of structurally diversified 1,4-dihydropyridines. RSC Adv., 2012, 2, 9763-9777
9. Dandapani, S.; Marcaurelle, L.A. Current strategies for diversity-oriented synthesis. Curr. Opin. Chem. Biol., 2010, 14, 362-370.
10. Houck, J.E.B.; Younai, A.; Shaw, J.T. Recent advances in multicomponent reactions for diversity-oriented synthesis. Curr. Opin. Chem. Biol., 2010, 14, 371-382;
11. Zhu, J.; Bienaymé, H. (Eds). Multicomponent Reactions; Wiley-VCH: Weinheim, 2005, ISBN 3-527-30806-7.
12. Toure, B.B.; Hall, D.G. Natural product synthesis using multicomponent reaction strategies. Chem. Rev., 2009, 109, 4439-4486;
13. Jang, B.; Shi, F.; Tu, S.-T. Microwave-assisted multicomponent reactions in the heterocyclic chemistry. Curr. Org. Chem., 2010, 14, 357-378;
14. Bannwarth, W.; Felder, E. (Eds). Combinatorial Chemistry: A Practical Approach; Wiley-VCH: Weinheim, 2000.
15. Karki, R.; Thapa, P.; Kang, M.J.; Jeong, T.C.; Nam, J.M.; Kim, H.L.; Na, Y.; Cho, W.J.; Kwon, Y.; Lee, E.S. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines. Bioorg. Med. Chem., 2010, 18, 3066-3077;
16. Tenti, G.; Egea, J.; Villarroya, M.; León, R.; Fernández, J.C.; Padín, J.F.; Sridharan, V.; Ramos, M.T.; Menéndez, J.C. Identification of 4,6-diaryl-1,4-dihydropyridines as a new class of neuroprotective agents. Med. Chem. Comm., 2013, 4(3), 590-594;
17. Balalaie, S.; Baoosi, L.; Tahoori, F.; Rominger, F.; Bijanzadeh, H. R. Synthesis of polysubstituted 1,4-dihydropyridines via threecomponent reaction. Tetrahedron, 2013, 69(2), 738-743;
18. Locatelli, A.; Cosconati, S.; Micucci, M.; Leoni, A.; Marinelli, L.; Bedini, A.; Ioan, P.; Spampinato, S. M.; Novellino, E.; Chiarini, A.; Budriesi, R. Ligand based approach to L-type calcium channel by imidazo[2,1-b]thiazole-1,4-dihydropyridines: from heart activity to brain affinity. J. Med. Chem., 2013, 56(10), 3866-3877.
19. Carosati, E.; Ioan, P.; Micucci, M.; Broccatelli, F.; Cruciani, G.; Zhorov, B.S.; Chiarini, A.; Budriesi, R. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (Part 2): Action in other targets and antitargets. Curr. Med. Chem., 2012, 19(25), 4306-4323;
20. Gati, W.; Rammah, M.M.; Rammah, M.B.; Couty, F.; Evano, G. De novo synthesis of 1,4-dihydropyridines and pyridines. Chem. Soc., 2012, 134(22), 9078-9081;
21. 2 cannabinoid receptor ligands part 2: Discovery of new agonists endowed with protective effect against experimental colitis. J. Med. Chem., 2012, 55(20), 8948-8952.
22. Sausins, A.; Duburs, G. Synthesis of 1,4-dihydropyridines by cyclocondensation reactions. Heterocycles, 1988, 27, 269-289
23. Malaise, W.J.; Mathias, P.C.F. Stimulation of insulin release by organic calcium-agonist. Diabetologia, 1985, 28, 153-156
24. Edraki, N.; Mehdipou, A. R.; Khoshneviszadeh, M.; Miri, R. Dihydropyridines: Evaluation of their current and future pharmacological applications. Drug Discov. Today, 2009, 14, 1058-1066
25. Fernandes, M.A.S.; Santos, M.S.; Moreno, A.J.M.; Chernova, L.; Krauze, A.; Duburs, G.; Vicente, J.A.F. Effects of 5-acetyl(carbamoyl)-6-methylsulfanyl-1,4-dihydropyridine-5-carbonitriles on rat liver mitochondrial function. Toxicol. in Vitro, 2009, 23, 1333-1341
26. Bahekar, S.K.; Shinde, D. Synthesis and anti-inflammatory activity of 1, 4 dihydropyridines. Acta Pharm., 2002, 52(4), 281-287
27. Kumar, R.S.; Idhayadhulla, A.; Nasser, A.J.A.; Selvin, J. Synthesis and antimicrobial activity of a new series of 1,4-dihydropyridine derivatives. J. Serb. Chem. Soc., 2011, 76, 1-11
28. Vijesh, A.M.; Isloor, A.M.; Peethambar, S.K.; Shivananda, K.N.; Arulmoli, T.; Isloor, N.A. Hantzsch reaction: Synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents. Eur. J. Med. Chem., 2011, 46, 5591-5597
29. Mannhold, R.; Jablonka, B.; Voigdt, W.; Schoenafinger, K.; Schravan, K. Calcium-and calmodulin-antagonism of elnadipine derivatives: comparative SAR. Eur. J. Med. Chem., 1992, 27, 229-235
30. Kawase, M.; Shah, A.; Gaveriya, H.; Motohashi, N.; Sakagami, H.; Varga, A.; Molnar, J. 3, 5-dibenzoyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells. Bioorg. Med. Chem., 2002, 10, 1051-1055
31. Berkels, B.; Roesen, R.; Dhein, S.; Fricke, U.; Klaus, W. Dihydropyridine calcium antagonist induced modulation of endothelial function – a review. Cardiovasc. Drug Rev., 1999, 17, 179-186
32. Chapman, R.W.; Danko, G.; Siegels, M.I. Effect of extra-and intracellular calcium blockers on histamine and antigen-induced bronchospasms in guinea pigs and rats. Pharmacology, 1984, 29, 282-291;
33. Xie, K.; Liu, Y.-C.; Cui, Y.; Wang, J.-G.; Fu, Y.; Mak, T.C.W. N-methyl-(R)-3-(tert-butyl)-sulfinyl-1,4-dihydropyridine: a novel NADH model compound. Molecules, 2007, 12, 415-422
34. Gaillard, S.; Papamicael, C.; Marsais, F.; Dupas, G.; Levacher, V. Preparation of 1,4-dihydroquinolines bearing a chiral sulfoxide group: New highly enantioselective recyclable NADH mimics. Synlett, 2005, 3, 441-444
35. Zhu, X.Q.; Wang, H.Y.; Wang, J.S.; Liu, Y.C. Application of NAD(P)H model Hantzsch 1,4-dihydropyridine as a mild reducing agent in preparation of cyclo compounds. J. Org. Chem., 2001, 66, 344-347.
36. Godfraid, T.; Miller, R.; Wibo, M. Calcium antagonism and calcium entry blockade. Pharmacol. Rev., 1986, 38, 321-416
37. Mager, P.P.; Coburn, R.A.; Solo, A.J.; Triggle, D.J.; Rothe, H. QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road ahead. Drug Des. Discov., 1992, 8, 273-289.
38. Bocker, R.H.; Guengerich, E.P. Oxidation of 4-aryl-and 4-alkylsubstituted 2,6-dimethyl-3,5-bis (alkoxycarbonyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450. J. Med. Chem., 1986, 29, 1596-1603.
39. Nasim, A.; Brychcy, T. Genetic effects of acridine compounds. Mutat. Res. Rev. Genet. Toxicol., 1979, 65, 261-268;
40. Reid, J.L.; Meredith, P.A.; Pasanisi, F. Clinical pharmacological aspects of calcium antagonists and their therapeutic role in hypertension. J. Cardiovasc. Pharmacol., 1985, 7, S18-S20.
41. Baumert, C.; Günthel, M.; Krawczyka, S.; Hemmer, M.; Wersiga, T.; Langner, A.; Molnár, J.; Lagec, H.; Hilgerotha, A. Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: Novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties. Bioorg. Med. Chem., 2013, 21, 166-177;
42. Tasaka, S.; Ohmori, H.; Gomi, N.; Iino M, Machida, T.; Kiue, A.; Naito, S.; Kuwano, M. Synthesis and structure-activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance. Bioorg. Med. Chem. Lett., 2001, 11, 275-277.
43. Leblois, D.; Piessard, S.; Le Baut, G.; Kumar, P.; Brion, J.D.; Sparfel, L.; Sanchez, R.Y.; Juge, M.; Petit, J.Y.; Welin, L. Pyrophthalones VII. Synthesis and anti-inflammatory activity of 2-(4-pyridinyl)indane-1,3-diones diversely substituted on the benzene ring. Eur. J. Med. Chem., 1987, 22, 229-238.
44. Cave, A.; Leboeuf, M.; Waterman, P.G. In: Alkaloids: Chemical and Biological Perspective; Pelletier, S.W. Ed.; Wiley: London, 1987, vol. 5, p. 245
45. Arango, G.J.; Cortes, D.; Cassels, B.K.; Cave, A.; Merienne, C. Azafluorenones from Oxandra cf. major. biogenetic considerations. Phytochemistry, 1987, 26, 2093-2098
46. Goulart, M.O.F.; Sant’ana, A.E.G.; de Oliveira, A.B.; de Oliveira, G.G.; Maia, J.G.S. Azafluorenones and azaanthra-quinone from Guatteria dielsiana. Phytochemistry, 1986, 25, 1691-1695.
47. Cullen, J.; Hinkhouse, M.; Grady, M.; Gaut, A.; Liu, J.; Zhang, Y.; Weydert, C.; Domann, F.; Oberley, L. Dicumarol inhibition of NADPH: Quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res., 2003, 63, 5513-5520;
48. Mironov, A.; Colanzi, A.; Polishchuk, R.; Beznoussenko, G.; Mironov, A.; Fusella, A.; Di Tullio, G.; Silletta, M.; Corda, D.; De Matteis, M.; Luini, A. Dicumarol, an inhibitor of ADP-ribosylation of CtBP3/BARS, fragments Golgi non-compact tubular zones and inhibits intra-Golgi transport. Eur. J. Cell. Biol., 2004, 83, 263-279.
49. Palmisanoa, G.; Tibiletti, F.; Penoni, A.; Colomboa, F.; Tollari, S.; Garella, D.; Tagliapietra, S.; Cravotto, G. Ultrasound-enhanced one-pot synthesis of 3-(Het)arylmethyl-4-hydroxycoumarins in water. Ultrason. Sonochem., 2011, 18, 652-660.
50. Arya, A.K.; Kumar, M. Base catalyzed multicomponent synthesis of spiroheterocycles with fused heterosystems. Mol. Divers., 2011, 15, 781-789
51. Arya, A.K.; Gupta, S.K.; Kumar, M. A domino protocol for the efficient synthesis of structurally diverse benzothiazolylquinoline-2,5-diones and their spiro analogues. Tetrahedron Lett., 2012, 53, 6035-6038
52. 4]) as efficient promoter for the synthesis of structurally diverse spiroheterocycles. Tetrahedron Lett., 2012, 53, 4604-4608
53. Arya, A.K.; Kumar, M. An efficient green chemical approach for the synthesis of structurally diverse spiroheterocycles with fused heterosystems. Green Chem., 2011, 13, 1332-1338
54. Khandelwal, S.; Rajawat, A.; Kumar, M. An efficient and environmentally benign four-component domino protocol for the synthesis of spirooxindoles spiroannulated with fused heterosystems of privileged heterocycles. Curr. Bioact. Compd., 2013, (In Press)
55. Kumar, M.; Sharma, K.; Sharma, D.K.; Arya, A.K. An efficient, ionic liquid mediated one-pot, three component sequential synthesis of 3-benzothiazolyl-2-styrylquinazolin-4(3H)-ones. Tetrahedron Lett., 2013, 54, 878-882.
56. Kumar, M.; Sharma, K.; Samarth, R. M.; Kumar, A. Synthesis and antioxidant activity of quinolinobenzothaizinones. Eur. J. Med. Chem., 2010, 45, 4467-4472.